BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3984570)

  • 1. [Serous borderline ovarian tumors].
    Zipprich K; Albrecht G; Canzler E
    Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Borderline tumors of the ovary: a multicenter study in 137 patients].
    Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of borderline ovarian tumors.
    Tîrnovanu MC; Amancei S; Dumitrescu A; Onofriescu M; Dumitraşcu I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1069-75. PubMed ID: 23700890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical-pathological relationships of potenially malignant cystadenomas of the ovaries].
    Gáti E; Töttössy B; Sugár J
    Zentralbl Gynakol; 1978; 100(15):978-84. PubMed ID: 706881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Our experience in treating ovarian tumors with borderline malignancy].
    Ivanov S; Kŭrlov T; Ivanov S
    Akush Ginekol (Sofiia); 2000; 39(1):39-41. PubMed ID: 10826337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of borderline ovarian tumors.
    Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
    Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biologic behavior of low-grade papillary serous carcinoma of the ovary.
    Julian CG; Woodruff JD
    Obstet Gynecol; 1972 Dec; 40(6):860-7. PubMed ID: 4636916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ovarian serous borderline tumor: the prognostic relation to the pathologic features and management].
    Zhou XR; Du XG
    Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):601-3, 637. PubMed ID: 7712874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extent of psammoma carcinomas of the ovary--a clinical, DNA flow cytophotometric and morphometric image analysis study].
    Kühn W; Feichter GE; Beier K; Rummel HH; Abel U; Kaufmann M
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):597-604. PubMed ID: 2170226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A serous cystadenoma of the ovary of borderline malignancy with a fifteen-year history. A case report].
    Nagata O; Aramaki S; Iino H; Ishikawa S; Yoshida H; Azekami M; Yamaguchi Y; Iwasa T; Matsukuma K; Iwata Y
    Gan No Rinsho; 1990 Apr; 36(5):669-73. PubMed ID: 2325270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous and seromucinous infantile ovarian cystadenomas--a study of 42 cases.
    Massicot R; Rousseau V; Darwish AA; Sauvat F; Jaubert F; Nihoul-Fékété C
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):64-7. PubMed ID: 18996636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian serous cystadenoma.
    Tarlowska L; Sikorowa L; Piatkowski Z
    Pol Med J; 1972; 11(2):368-79. PubMed ID: 5071524
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.